Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

MYEOV

Identity

Other namesOCIM
HGNC MYEOV
Location 11q13
Local_order 350 kb centromeric of cyclin D1
Note detected by application of the NIH/3T3 tumorigenicity assay. However MYEOV cDNA was not positive in NIH/3T3 assay.

DNA/RNA

Description 2 exons; 3.5 kb transcript represents unspliced mRNA.
Transcription main transcript 2.8 kb (broad band because of alternative splice products); minor transcript 3.5 kb.; coding sequence 313 or 255 amino acids. In normal tissues hardly any expression detectable. High expression in a subset of multiple myeloma cell lines with a t(11;14)(q13;q32) and in breast tumors and esophageal squamous cell carcinomas with or without 11q13 amplification.

Protein

Description 313 or 255 amino acids; contains one RNP-1 motif and 6 regions that might function as a transmembrane domain. Leucine-rich stretch at C-terminal.
Expression 5Ô UTR inhibits efficient translation of the protein
Localisation in endoplasmic reticulum and mitochondria.

Implicated in

Entity t(11;14)(q13;q32)
Disease subset of multiple myeloma cell lines with t(11;14)(q13;q32)
Cytogenetics myeov overexpression due to juxtaposition to the 5' enhancer or the most telomeric 3' enhancer of the immunoglobulin heavy chain (IgH).
  
Entity 11q13 amplification and/or overexpression
Disease breast cancer; esophageal squamous cell carcinomas.
Prognosis MYEOV DNA amplification correlated with estrogen and progesterone receptor-positive cancer, invasive lobular carcinoma type and axillary nodal involvement. In contrast to Cyclin D1 amplification, no association with disease outcome could be found.
  

External links

Nomenclature
HGNCMYEOV   7563
Entrez_GeneMYEOV  26579  myeloma overexpressed gene (in a subset of t(11;14) positive multiple myelomas)
Cards
AtlasMYEOVID395
GeneCardsMYEOV
EnsemblMYEOV [Search_View]   ENSG00000172927 [Gene_View]
GenatlasMYEOV
GeneLynxMYEOV
eGenomeMYEOV
euGene26579
Genomic and cartography
GoldenPathMYEOV  -  11q13   chr11:68818198-68821330 +  11q13.2   [Description]    (hg18-Mar_2006)
EnsemblMYEOV - 11q13.2 [CytoView]
NCBIMapview
OMIMDisease map [OMIM]
HomoloGeneMYEOV
Gene and transcription
GenbankAJ223366 [ ENTREZ ]
GenbankAJ223366 [ ENTREZ ]
GenbankAK026148 [ ENTREZ ]
GenbankAK290121 [ ENTREZ ]
GenbankBC011815 [ ENTREZ ]
RefSeqNM_138768 [ SRS ]    NM_138768 [ ENTREZ ]
RefSeqAC_000054 [ SRS ]    AC_000054 [ ENTREZ ]
RefSeqAC_000143 [ SRS ]    AC_000143 [ ENTREZ ]
RefSeqNC_000011 [ SRS ]    NC_000011 [ ENTREZ ]
RefSeqNT_033903 [ SRS ]    NT_033903 [ ENTREZ ]
RefSeqNW_001838026 [ SRS ]    NW_001838026 [ ENTREZ ]
RefSeqNW_925106 [ SRS ]    NW_925106 [ ENTREZ ]
AceViewMYEOV AceView - NCBI
UnigeneHs.523848 [ SRS ]    Hs.523848 [ NCBI ]     HS523848 [ spliceNest ]
Fast-db11061 (alternative variants)
Protein : pattern, domain, 3D structure
SwissProtQ96EZ4 [ SRS]    Q96EZ4 [ EXPASY ]     Q96EZ4 [ INTERPRO ]     Q96EZ4 [ UNIPROT ]
CluSTrQ96EZ4
BlocksQ96EZ4
HPRD16130
Protein Interaction databases
DIPQ96EZ4
IntActQ96EZ4
Polymorphism : SNP, mutations, diseases
OMIM605625    [ map ]   
GENECLINICS605625
SNPMYEOV [dbSNP-NCBI]  
SNPNM_138768 [SNP-NCI]  
SNPMYEOV [GeneSNPs - Utah]  MYEOV] [HGBASE - SRS]
HAPMAPMYEOV [HAPMAP]  
HGMDMYEOV
General knowledge
Family BrowserMYEOV [UCSC Family Browser]
SOURCENM_138768
SMDHs.523848
SAGEHs.523848
PubGeneMYEOV
TreeFamMYEOV
CTD26579 [Comparative ToxicoGenomics Database]
Other databases
Probes
ProbeMYEOV Related clones (RZPD - Berlin)
PubMed
PubMed8 Pubmed reference(s) in LocusLink

Bibliography

Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).
Janssen JW, Vaandrager JW, Heuser T, Jauch A, Kluin PM, Geelen E, Bergsagel PL, Kuehl WM, Drexler HG, Otsuki T, Bartram CR, Schuuring E
Blood. 2000 ; 95 (8) : 2691-2698.
PMID 10753852
 
MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.
Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J
Journal of human genetics. 2002 ; 47 (9) : 460-464.
PMID 12202983
 
MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.
Janssen JW, Cuny M, Orsetti B, Rodriguez C, Vallˆ©s H, Bartram CR, Schuuring E, Theillet C
International journal of cancer. Journal international du cancer. 2002 ; 102 (6) : 608-614.
PMID 12448002
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written12-2002Johannes W.G. Janssen
Janssen Institut für Humangenetik Universitätsklinikum Heidelberg Im Neuenheimer Feld 328 D-69120 Heidelberg, Germany

Citation

This paper should be referenced as such :
Janssen JWG . MYEOV. Atlas Genet Cytogenet Oncol Haematol. December 2002 .
URL : http://AtlasGeneticsOncology.org/Genes/MYEOVID395.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Mon Aug 11 21:15:41 2008


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

j.l.huret@chu-poitiers.fr.